vs
Kellanova（K）とTENET HEALTHCARE CORP（THC）の財務データ比較。上の社名をクリックして会社を切り替えられます
TENET HEALTHCARE CORPの直近四半期売上が大きい（$5.5B vs $3.3B、Kellanovaの約1.7倍）。TENET HEALTHCARE CORPの純利益率が高く（11.7% vs 9.5%、差は2.2%）。TENET HEALTHCARE CORPの前年同期比売上増加率が高い（9.0% vs 0.8%）。TENET HEALTHCARE CORPの直近四半期フリーキャッシュフローが多い（$367.0M vs $359.0M）。過去8四半期でTENET HEALTHCARE CORPの売上複合成長率が高い（1.5% vs -9.0%）
ケラノバ（旧社名：ケロッグ社）はマーズ・インク傘下の米国多国籍食品製造企業で、本社はイリノイ州シカゴに所在する。2023年10月2日に現在の社名に変更され、同時に北米のシリアル事業を分社化してWKケロッグ社を設立した。
テネット・ヘルスケア・コーポレーションは米国ダラスに本社を置く営利目的の多国籍医療サービス企業です。USPIをはじめとするブランド・子会社・合弁事業・提携先を通じ、65の病院と450以上の医療施設を運営するほか、Conifer Health Solutionsで医療システムなどの顧客向けに医療支援サービスを提供しています
K vs THC — 直接比較
損益計算書 — Q3 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $3.3B | $5.5B |
| 純利益 | $309.0M | $644.0M |
| 粗利率 | 33.3% | — |
| 営業利益率 | 13.9% | 15.4% |
| 純利益率 | 9.5% | 11.7% |
| 売上前年比 | 0.8% | 9.0% |
| 純利益前年比 | -15.8% | 12.6% |
| EPS（希薄化後） | $0.88 | $4.22 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | — | $5.5B | ||
| Q3 25 | $3.3B | $5.3B | ||
| Q2 25 | $3.2B | $5.3B | ||
| Q1 25 | $3.1B | $5.2B | ||
| Q4 24 | $3.1B | $5.1B | ||
| Q3 24 | $3.2B | $5.1B | ||
| Q2 24 | $3.2B | $5.1B | ||
| Q1 24 | $3.2B | $5.4B |
| Q4 25 | — | $644.0M | ||
| Q3 25 | $309.0M | $579.0M | ||
| Q2 25 | $299.0M | $522.0M | ||
| Q1 25 | $304.0M | $622.0M | ||
| Q4 24 | $365.0M | $572.0M | ||
| Q3 24 | $367.0M | $681.0M | ||
| Q2 24 | $344.0M | $477.0M | ||
| Q1 24 | $267.0M | $2.3B |
| Q4 25 | — | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 34.0% | — | ||
| Q1 25 | 34.3% | — | ||
| Q4 24 | 37.7% | — | ||
| Q3 24 | 36.4% | — | ||
| Q2 24 | 36.4% | — | ||
| Q1 24 | 32.2% | — |
| Q4 25 | — | 15.4% | ||
| Q3 25 | 13.9% | 16.8% | ||
| Q2 25 | 13.7% | 15.6% | ||
| Q1 25 | 13.9% | 18.1% | ||
| Q4 24 | 17.0% | 16.2% | ||
| Q3 24 | 14.1% | 21.3% | ||
| Q2 24 | 15.4% | 14.9% | ||
| Q1 24 | 12.3% | 61.2% |
| Q4 25 | — | 11.7% | ||
| Q3 25 | 9.5% | 10.9% | ||
| Q2 25 | 9.3% | 9.9% | ||
| Q1 25 | 9.9% | 11.9% | ||
| Q4 24 | 11.7% | 11.3% | ||
| Q3 24 | 11.4% | 13.3% | ||
| Q2 24 | 10.8% | 9.3% | ||
| Q1 24 | 8.3% | 43.5% |
| Q4 25 | — | $4.22 | ||
| Q3 25 | $0.88 | $3.86 | ||
| Q2 25 | $0.85 | $3.14 | ||
| Q1 25 | $0.87 | $4.27 | ||
| Q4 24 | $1.05 | $3.79 | ||
| Q3 24 | $1.05 | $4.89 | ||
| Q2 24 | $1.00 | $2.64 | ||
| Q1 24 | $0.78 | $21.38 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $240.0M | $2.9B |
| 総負債低いほど良い | $4.3B | $13.1B |
| 株主資本純資産 | $4.2B | $4.2B |
| 総資産 | $15.6B | $29.7B |
| 負債/資本比率低いほどレバレッジが低い | 1.02× | 3.10× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $2.9B | ||
| Q3 25 | $240.0M | $3.0B | ||
| Q2 25 | $354.0M | $2.6B | ||
| Q1 25 | $330.0M | $3.0B | ||
| Q4 24 | $694.0M | $3.0B | ||
| Q3 24 | $569.0M | $4.1B | ||
| Q2 24 | $272.0M | $2.9B | ||
| Q1 24 | $242.0M | $2.5B |
| Q4 25 | — | $13.1B | ||
| Q3 25 | $4.3B | $13.1B | ||
| Q2 25 | $4.3B | $13.1B | ||
| Q1 25 | $5.0B | $13.1B | ||
| Q4 24 | $5.0B | $13.1B | ||
| Q3 24 | $5.1B | $12.8B | ||
| Q2 24 | $5.0B | $12.8B | ||
| Q1 24 | $4.4B | $12.8B |
| Q4 25 | — | $4.2B | ||
| Q3 25 | $4.2B | $4.0B | ||
| Q2 25 | $4.1B | $3.7B | ||
| Q1 25 | $3.9B | $4.2B | ||
| Q4 24 | $3.8B | $4.2B | ||
| Q3 24 | $3.6B | $3.8B | ||
| Q2 24 | $3.3B | $3.5B | ||
| Q1 24 | $3.2B | $3.5B |
| Q4 25 | — | $29.7B | ||
| Q3 25 | $15.6B | $29.4B | ||
| Q2 25 | $15.9B | $28.7B | ||
| Q1 25 | $15.5B | $29.2B | ||
| Q4 24 | $15.6B | $28.9B | ||
| Q3 24 | $15.8B | $29.4B | ||
| Q2 24 | $15.3B | $29.3B | ||
| Q1 24 | $15.3B | $28.9B |
| Q4 25 | — | 3.10× | ||
| Q3 25 | 1.02× | 3.26× | ||
| Q2 25 | 1.05× | 3.49× | ||
| Q1 25 | 1.28× | 3.13× | ||
| Q4 24 | 1.32× | 3.14× | ||
| Q3 24 | 1.40× | 3.33× | ||
| Q2 24 | 1.51× | 3.67× | ||
| Q1 24 | 1.40× | 3.70× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $503.0M | $731.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $359.0M | $367.0M |
| FCFマージンFCF / 売上 | 11.0% | 6.6% |
| 設備投資強度設備投資 / 売上 | 4.4% | 6.6% |
| キャッシュ転換率営業CF / 純利益 | 1.63× | 1.14× |
| 直近12ヶ月FCF直近4四半期 | $599.0M | $2.5B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $731.0M | ||
| Q3 25 | $503.0M | $1.1B | ||
| Q2 25 | $169.0M | $936.0M | ||
| Q1 25 | $116.0M | $815.0M | ||
| Q4 24 | $467.0M | $-331.0M | ||
| Q3 24 | $553.0M | $1.0B | ||
| Q2 24 | $376.0M | $747.0M | ||
| Q1 24 | $364.0M | $586.0M |
| Q4 25 | — | $367.0M | ||
| Q3 25 | $359.0M | $778.0M | ||
| Q2 25 | $21.0M | $743.0M | ||
| Q1 25 | $-60.0M | $642.0M | ||
| Q4 24 | $279.0M | $-661.0M | ||
| Q3 24 | $410.0M | $829.0M | ||
| Q2 24 | $234.0M | $602.0M | ||
| Q1 24 | $209.0M | $346.0M |
| Q4 25 | — | 6.6% | ||
| Q3 25 | 11.0% | 14.7% | ||
| Q2 25 | 0.7% | 14.1% | ||
| Q1 25 | -1.9% | 12.3% | ||
| Q4 24 | 8.9% | -13.0% | ||
| Q3 24 | 12.7% | 16.2% | ||
| Q2 24 | 7.3% | 11.8% | ||
| Q1 24 | 6.5% | 6.4% |
| Q4 25 | — | 6.6% | ||
| Q3 25 | 4.4% | 5.3% | ||
| Q2 25 | 4.6% | 3.7% | ||
| Q1 25 | 5.7% | 3.3% | ||
| Q4 24 | 6.0% | 6.5% | ||
| Q3 24 | 4.4% | 4.2% | ||
| Q2 24 | 4.4% | 2.8% | ||
| Q1 24 | 4.8% | 4.5% |
| Q4 25 | — | 1.14× | ||
| Q3 25 | 1.63× | 1.83× | ||
| Q2 25 | 0.57× | 1.79× | ||
| Q1 25 | 0.38× | 1.31× | ||
| Q4 24 | 1.28× | -0.58× | ||
| Q3 24 | 1.51× | 1.53× | ||
| Q2 24 | 1.09× | 1.57× | ||
| Q1 24 | 1.36× | 0.25× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
K
| Retail Channel Snacks | $2.0B | 62% |
| Retail Channel Cereal | $678.0M | 21% |
| Noodlesand Other | $280.0M | 9% |
| Frozen And Specialty Channels | $275.0M | 8% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
